Sotorasib intermediate（CAS:1534369-41-9）

2-Fluoro-6-hydroxybenzeneboronic acid pinacol ester

CAS:1534369-41-9

Yuanshu Pharmaceutical Technology Co.,Ltd. was established in 2015 in Nanjing ( Life Science and Technology Innovation Park ),  which  focus  on medicines  and  fine  electronic  chemicals field ,  and  be  entitled  as  ' Jiangsu Good Enterprise ', awarded  ISO 9001 certification in 2017, besides, as a ' National High Technology Enterprise ’honour in year 2018.Yuanshu was listed on the Science and Technology Innovation Board of Jiangsu Equity Trading Center in year 2020.

Yuanshu Pharmaceutical Technology Co., Ltd. has a modern R&D center in Jiangsu Life Science and Technology Innovation Park.  We have international advanced equipments, management system and functional departments.  Yuanshu focuses on the CRO and CDMO of clinical drug intermediates with high synthesis difficulty, and the development of ADC drug. The R&D has a professional  process  development  team  and follows  strict  confidentiality  system and  intellectual property protection system for customized  projects.  At present,  18 patents have been authorized and 11 patents have been accepted.

The  concept of our company  is to adhere to scientific  and  technological  innovation  is the source power of enterprise  development! We will strive to become a professional manufacturer and supplier in the field of medicines and materials.